Janux Therapeutics, Inc. ( JANX) - Stock Earnings
JANX Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 5, 2026, midnight | — / — | — | — / — | — |
JANX Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -31.9 million USD | 7.9 million USD |
| 2026Q1 | -24.4 million USD | 3.7 million USD |
| 2026Q2 | -22.0 million USD | 10.3 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
JANX Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -58.3 million USD | 8.1 million USD |
| 2024 | -69.0 million USD | 10.6 million USD |
| 2025 | -113.6 million USD | 10.0 million USD |
| 2026 Est. | — | — |
JANX
Price: $16.51
52 week price:
Earnings Per Share: -1.64 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 219876
Market Capitalization: 1.0 billion